ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative

Core Insights - ProPhase Labs, Inc. is exploring a potential reverse merger with a digital asset-focused operating company to enhance its business operations and market positioning [1][3] - The Board has approved a strategic treasury initiative to acquire and hold select digital assets, including Bitcoin, aiming to diversify the company's treasury strategy and enhance long-term shareholder value [2][3] - CEO Ted Karkus emphasized the importance of assessing opportunities at the intersection of life sciences and financial innovation, indicating that the merger could create scalable value while preserving existing shareholder value [4] Company Overview - ProPhase Labs is a next-generation biotech, genomics, and consumer products company focused on revolutionizing healthcare through innovative solutions, including Whole Genome Sequencing and diagnostic development [5] - The company is committed to executional excellence, smart diversification, and a synergistic approach to maximize long-term value [5]